Research Article
BEZ235 Increases the Sensitivity of Hepatocellular Carcinoma to Sorafenib by Inhibiting PI3K/AKT/mTOR and Inducing Autophagy
Figure 3
The effect of various treatments on the cell cycle in Huh7 or Huh7R, as determined with flow cytometry and western blot. (a) Huh7 or Huh7R cells stained with propidium iodide after treatment for 24 h. (SFB, 4 μM; BEZ235, 0.25 μM; SFB, 4 μM + BEZ, 0.25 μM). Cell-cycle distribution was analyzed by flow cytometry. (b) Western blot analysis revealed the expression of the key G1-phase regulatory protein after treatment for 24 h: cyclin-D1 and p-Rb and p-GSK3β. (SFB, 4 μM; BEZ235, 0.25 μM; and SFB, 4 μM + BEZ, + 0.25 μM). Data are presented as , . , all versus SFB single agent. SFB: sorafenib; BEZ: BEZ235; SFB + BEZ: sorafenib combined with BEZ235.
(a) |
(b) |